Pub Date : 2026-01-02DOI: 10.1161/CIRCRESAHA.125.325793
Rebecca L Harper, Patrick M Lelliott, Shawn B Bender, Alexander R Pinto
The cardiovascular system, composed of the heart and vasculature, is essential for blood circulation, nutrient exchange, and waste removal. In the past, our understanding of cardiovascular development and function has largely been shaped by bulk tissue analyses, which obscures cellular heterogeneity. The emergence of single-cell omics has transformed the field by enabling unbiased transcriptional profiling of individual cells, revealing the diversity of stem cells and progenitor cells driving embryogenesis, resulting in the various mature cardiovascular cell types in the adult heart and vasculature. This technology has provided unprecedented insights into the molecular mechanisms governing cardiovascular development and function by identifying novel cell subpopulations, characterizing their unique properties, and tracing their temporal evolution through advanced analytical approaches. In this review, we discuss how single-cell omics has reshaped our understanding of cardiovascular developmental biology, highlight key analytical tools and emerging approaches, examine preclinical models that have facilitated these discoveries, and explore how these technologies have defined the cellular landscape of the heart and vasculature. We conclude by looking ahead to emerging technologies such as spatial transcriptomics and clonal barcoding for lineage tracing, as well as new strategies in addressing the gender gap in cardiovascular research.
{"title":"Unraveling Cardiovascular Development and Function: Insights From Single-Cell Omics.","authors":"Rebecca L Harper, Patrick M Lelliott, Shawn B Bender, Alexander R Pinto","doi":"10.1161/CIRCRESAHA.125.325793","DOIUrl":"https://doi.org/10.1161/CIRCRESAHA.125.325793","url":null,"abstract":"<p><p>The cardiovascular system, composed of the heart and vasculature, is essential for blood circulation, nutrient exchange, and waste removal. In the past, our understanding of cardiovascular development and function has largely been shaped by bulk tissue analyses, which obscures cellular heterogeneity. The emergence of single-cell omics has transformed the field by enabling unbiased transcriptional profiling of individual cells, revealing the diversity of stem cells and progenitor cells driving embryogenesis, resulting in the various mature cardiovascular cell types in the adult heart and vasculature. This technology has provided unprecedented insights into the molecular mechanisms governing cardiovascular development and function by identifying novel cell subpopulations, characterizing their unique properties, and tracing their temporal evolution through advanced analytical approaches. In this review, we discuss how single-cell omics has reshaped our understanding of cardiovascular developmental biology, highlight key analytical tools and emerging approaches, examine preclinical models that have facilitated these discoveries, and explore how these technologies have defined the cellular landscape of the heart and vasculature. We conclude by looking ahead to emerging technologies such as spatial transcriptomics and clonal barcoding for lineage tracing, as well as new strategies in addressing the gender gap in cardiovascular research.</p>","PeriodicalId":10147,"journal":{"name":"Circulation research","volume":"138 1","pages":"e325793"},"PeriodicalIF":16.2,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145892042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-02DOI: 10.1161/RES.0000000000000743
{"title":"Meet the First Authors.","authors":"","doi":"10.1161/RES.0000000000000743","DOIUrl":"https://doi.org/10.1161/RES.0000000000000743","url":null,"abstract":"","PeriodicalId":10147,"journal":{"name":"Circulation research","volume":"138 1","pages":"e000743"},"PeriodicalIF":16.2,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145891864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-02DOI: 10.1161/CIRCRESAHA.125.328065
Nathan R Tucker, Eric R Gamazon
{"title":"Molecular Phenotyping at Single-Cell Resolution for Cardiovascular Disease.","authors":"Nathan R Tucker, Eric R Gamazon","doi":"10.1161/CIRCRESAHA.125.328065","DOIUrl":"https://doi.org/10.1161/CIRCRESAHA.125.328065","url":null,"abstract":"","PeriodicalId":10147,"journal":{"name":"Circulation research","volume":"138 1","pages":"e328065"},"PeriodicalIF":16.2,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145892019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"OTUD7a, a Deubiquitinating Enzyme, Is an Inducer of Maladaptive Hypertrophy.","authors":"Maurizio Forte, Giacomo Frati, Sebastiano Sciarretta","doi":"10.1161/CIRCRESAHA.125.327776","DOIUrl":"https://doi.org/10.1161/CIRCRESAHA.125.327776","url":null,"abstract":"","PeriodicalId":10147,"journal":{"name":"Circulation research","volume":"138 1","pages":"e327776"},"PeriodicalIF":16.2,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145892066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-02DOI: 10.1161/CIRCRESAHA.125.325795
Kai Li, Samaneh Samiei, Daryna Pikulska, Sebastian Foecking, Christoph Kuppe
Single-cell and spatial transcriptomics technologies have transformed the landscape of cardiovascular research, leading to novel insights into cellular heterogeneity and tissue architecture in health and disease. These technologies enable researchers to deconvolute complex tissues and map gene expression patterns within their spatial contexts, providing critical information on the interplay between cell types and pathways affecting tissue regeneration or progression to fibrosis. This review presents an overview of the recently developed applications of single-cell and spatial transcriptomics methods and their impact on cardiovascular research. We discuss the principles underlying emerging solutions to process fixed and low-integrity RNA samples like formalin-fixed paraffin-embedded tissues. In addition, we highlight advances in high-resolution spatial transcriptomics assays, from imaging-based techniques like MERFISH (multiplexed error-robust fluorescence in situ hybridization) and Xenium to sequencing-based platforms like Visium HD, Stereo-seq, and Open-ST, each contributing unique strengths for tissue-level analysis. The integration of these technologies with machine learning and multiomics approaches further enhances the ability to uncover novel biology. These approaches have already led to the discovery of spatially resolved gene expression patterns in human atherosclerosis, hypertrophic cardiomyopathy, myocardial infarction, and myocarditis. These case studies showcase how these methods can be applied to decode the cellular and molecular dynamics of human disease processes, identify potential novel therapeutic targets, and enable predictive modeling of cellular perturbations and patient disease trajectories. We provide a comprehensive overview of the growing data repository landscape, the principles and applications of novel machine learning approaches, which are becoming more and more standard analytical tools. Integrating these areas underscores how recent advancements in single-cell and spatial transcriptomics are offering an increasingly detailed and comprehensive understanding of the cellular landscape of cardiovascular disease while also highlighting the challenges and future directions that will shape innovations in cardiovascular biology and medicine.
{"title":"Advancing Cardiovascular Research With Single-Cell and Spatial Transcriptomics.","authors":"Kai Li, Samaneh Samiei, Daryna Pikulska, Sebastian Foecking, Christoph Kuppe","doi":"10.1161/CIRCRESAHA.125.325795","DOIUrl":"https://doi.org/10.1161/CIRCRESAHA.125.325795","url":null,"abstract":"<p><p>Single-cell and spatial transcriptomics technologies have transformed the landscape of cardiovascular research, leading to novel insights into cellular heterogeneity and tissue architecture in health and disease. These technologies enable researchers to deconvolute complex tissues and map gene expression patterns within their spatial contexts, providing critical information on the interplay between cell types and pathways affecting tissue regeneration or progression to fibrosis. This review presents an overview of the recently developed applications of single-cell and spatial transcriptomics methods and their impact on cardiovascular research. We discuss the principles underlying emerging solutions to process fixed and low-integrity RNA samples like formalin-fixed paraffin-embedded tissues. In addition, we highlight advances in high-resolution spatial transcriptomics assays, from imaging-based techniques like MERFISH (multiplexed error-robust fluorescence in situ hybridization) and Xenium to sequencing-based platforms like Visium HD, Stereo-seq, and Open-ST, each contributing unique strengths for tissue-level analysis. The integration of these technologies with machine learning and multiomics approaches further enhances the ability to uncover novel biology. These approaches have already led to the discovery of spatially resolved gene expression patterns in human atherosclerosis, hypertrophic cardiomyopathy, myocardial infarction, and myocarditis. These case studies showcase how these methods can be applied to decode the cellular and molecular dynamics of human disease processes, identify potential novel therapeutic targets, and enable predictive modeling of cellular perturbations and patient disease trajectories. We provide a comprehensive overview of the growing data repository landscape, the principles and applications of novel machine learning approaches, which are becoming more and more standard analytical tools. Integrating these areas underscores how recent advancements in single-cell and spatial transcriptomics are offering an increasingly detailed and comprehensive understanding of the cellular landscape of cardiovascular disease while also highlighting the challenges and future directions that will shape innovations in cardiovascular biology and medicine.</p>","PeriodicalId":10147,"journal":{"name":"Circulation research","volume":"138 1","pages":"e325795"},"PeriodicalIF":16.2,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145892190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BACKGROUNDPathological cardiac hypertrophy, an abnormal enlargement of cardiomyocytes and interstitial fibrosis in response to sustained injury or pressure overload, may lead to heart failure or even sudden death. Affected patients often also exhibit myocardial mitochondrial dysfunction and associated structural damage. Discovering more potent mitochondrial-targeting compounds may therefore hold great benefit, both for elucidating the mechanisms of cardiac hypertrophy and for treating affected patients.METHODSA series of novel 1-deoxynojirimycin (DNJ) derivatives was designed based on the unique binding mode of DNJ with OPA1 (optic atrophy 1). Two-step phenotypic screening was then performed using patient-specific cytoplasmic hybrid cells and iPSC-derived cardiomyocytes to identify promising candidates. Molecular dynamics simulations, combined with proteomic, biochemical, and physiological assays, were used to assess potential therapeutic mechanisms for mitochondrial disorders. OPA1 mutant cell lines were established to test candidate compound target specificity. Pathological cardiac hypertrophy models were established in mice and rats through angiotensin II induction and abdominal aortic constriction, enabling comprehensive evaluation of the candidates' preventive and therapeutic efficacy.RESULTSDNJ occupies a cavity formed by the GTPase domain of the OPA1 dimer, acting as an additional linker at the dimeric OPA1 interface. Here, we have designed and identified a novel DNJ derivative, DNJ5a. Compared with DNJ, DNJ5a exhibits enhanced in silico and in vitro binding specificity, providing additional anchor sites for direct OPA1 interaction. This interaction facilitates the stabilization of the OPA1 dimeric form to repair mitochondrial cristae damage and maintain inner membrane integrity. Comprehensive improvements in mitochondrial bioenergetics, Ca2+ homeostasis, mitophagy, and multidimensional functional responses are seen to result. In 2 rodent animal cardiac hypertrophy models, DNJ5a administration showed excellent preventive and therapeutic efficacy towards promoting mitochondrial health and cardiac function in vivo.CONCLUSIONSUnlike conventional mitochondrial drugs, which act to alleviate symptoms, DNJ5a can specifically target OPA1-GTPase and comprehensively improve mitochondrial health to ameliorate cardiac hypertrophy. These findings underscore mitochondrial abnormality as a primary contributor to pathological cardiac remodeling and present OPA1 as a strong potential drug target. The underlying mechanism of this novel agonist DNJ5a may pave the way towards developing many other promising mitochondrial-targeted therapeutics.
{"title":"Novel DNJ Derivative Ameliorates Cardiac Hypertrophy by Targeting OPA1 and Restoring Mitochondrial Health.","authors":"Xue Ding,Yangwei Jiang,Xiaochen Wang,Chujun Li,Zhengyi Kong,Lei Fu,Zhaoying Lei,Huajian Cai,Yufei Dong,Chengyu Shi,Xinwan Su,Tilo Kunath,Ziyi Wang,Damiano Buratto,Aifu Lin,Jianzhong Shao,Dong Zhang,Zhong Liu,Ping Liang,Ruhong Zhou,Qingfeng Yan","doi":"10.1161/circresaha.125.327407","DOIUrl":"https://doi.org/10.1161/circresaha.125.327407","url":null,"abstract":"BACKGROUNDPathological cardiac hypertrophy, an abnormal enlargement of cardiomyocytes and interstitial fibrosis in response to sustained injury or pressure overload, may lead to heart failure or even sudden death. Affected patients often also exhibit myocardial mitochondrial dysfunction and associated structural damage. Discovering more potent mitochondrial-targeting compounds may therefore hold great benefit, both for elucidating the mechanisms of cardiac hypertrophy and for treating affected patients.METHODSA series of novel 1-deoxynojirimycin (DNJ) derivatives was designed based on the unique binding mode of DNJ with OPA1 (optic atrophy 1). Two-step phenotypic screening was then performed using patient-specific cytoplasmic hybrid cells and iPSC-derived cardiomyocytes to identify promising candidates. Molecular dynamics simulations, combined with proteomic, biochemical, and physiological assays, were used to assess potential therapeutic mechanisms for mitochondrial disorders. OPA1 mutant cell lines were established to test candidate compound target specificity. Pathological cardiac hypertrophy models were established in mice and rats through angiotensin II induction and abdominal aortic constriction, enabling comprehensive evaluation of the candidates' preventive and therapeutic efficacy.RESULTSDNJ occupies a cavity formed by the GTPase domain of the OPA1 dimer, acting as an additional linker at the dimeric OPA1 interface. Here, we have designed and identified a novel DNJ derivative, DNJ5a. Compared with DNJ, DNJ5a exhibits enhanced in silico and in vitro binding specificity, providing additional anchor sites for direct OPA1 interaction. This interaction facilitates the stabilization of the OPA1 dimeric form to repair mitochondrial cristae damage and maintain inner membrane integrity. Comprehensive improvements in mitochondrial bioenergetics, Ca2+ homeostasis, mitophagy, and multidimensional functional responses are seen to result. In 2 rodent animal cardiac hypertrophy models, DNJ5a administration showed excellent preventive and therapeutic efficacy towards promoting mitochondrial health and cardiac function in vivo.CONCLUSIONSUnlike conventional mitochondrial drugs, which act to alleviate symptoms, DNJ5a can specifically target OPA1-GTPase and comprehensively improve mitochondrial health to ameliorate cardiac hypertrophy. These findings underscore mitochondrial abnormality as a primary contributor to pathological cardiac remodeling and present OPA1 as a strong potential drug target. The underlying mechanism of this novel agonist DNJ5a may pave the way towards developing many other promising mitochondrial-targeted therapeutics.","PeriodicalId":10147,"journal":{"name":"Circulation research","volume":"15 1","pages":""},"PeriodicalIF":20.1,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145847251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-18DOI: 10.1161/circresaha.125.327367
Richa Singhal,Ilaria Ferrari,Robert E Brainard,Kenneth R Brittian,Julia Chariker,Helen E Collins,Joseph B Moore Iv,Yibing Nong,Steven P Jones
{"title":"Temporal Dynamics in Murine Cardiac Transcriptome Following Myocardial Infarction.","authors":"Richa Singhal,Ilaria Ferrari,Robert E Brainard,Kenneth R Brittian,Julia Chariker,Helen E Collins,Joseph B Moore Iv,Yibing Nong,Steven P Jones","doi":"10.1161/circresaha.125.327367","DOIUrl":"https://doi.org/10.1161/circresaha.125.327367","url":null,"abstract":"","PeriodicalId":10147,"journal":{"name":"Circulation research","volume":"154 1","pages":""},"PeriodicalIF":20.1,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145771551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}